Epigenetic signatures of gestational diabetes mellitus on cord blood methylation

Abstract Background Intrauterine exposure to gestational diabetes mellitus (GDM) confers a lifelong increased risk for metabolic and other complex disorders to the offspring. GDM-induced epigenetic modifications modulating gene regulation and persisting into later life are generally assumed to media...

Full description

Bibliographic Details
Main Authors: Larissa Haertle, Nady El Hajj, Marcus Dittrich, Tobias Müller, Indrajit Nanda, Harald Lehnen, Thomas Haaf
Format: Article
Language:English
Published: BMC 2017-03-01
Series:Clinical Epigenetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13148-017-0329-3
_version_ 1818243262195957760
author Larissa Haertle
Nady El Hajj
Marcus Dittrich
Tobias Müller
Indrajit Nanda
Harald Lehnen
Thomas Haaf
author_facet Larissa Haertle
Nady El Hajj
Marcus Dittrich
Tobias Müller
Indrajit Nanda
Harald Lehnen
Thomas Haaf
author_sort Larissa Haertle
collection DOAJ
description Abstract Background Intrauterine exposure to gestational diabetes mellitus (GDM) confers a lifelong increased risk for metabolic and other complex disorders to the offspring. GDM-induced epigenetic modifications modulating gene regulation and persisting into later life are generally assumed to mediate these elevated disease susceptibilities. To identify candidate genes for fetal programming, we compared genome-wide methylation patterns of fetal cord bloods (FCBs) from GDM and control pregnancies. Methods and results Using Illumina’s 450K methylation arrays and following correction for multiple testing, 65 CpG sites (52 associated with genes) displayed significant methylation differences between GDM and control samples. Four candidate genes, ATP5A1, MFAP4, PRKCH, and SLC17A4, from our methylation screen and one, HIF3A, from the literature were validated by bisulfite pyrosequencing. The effects remained significant after adjustment for the confounding factors maternal BMI, gestational week, and fetal sex in a multivariate regression model. In general, GDM effects on FCB methylation were more pronounced in women with insulin-dependent GDM who had a more severe metabolic phenotype than women with dietetically treated GDM. Conclusions Our study supports an association between maternal GDM and the epigenetic status of the exposed offspring. Consistent with a multifactorial disease model, the observed FCB methylation changes are of small effect size but affect multiple genes/loci. The identified genes are primary candidates for transmitting GDM effects to the next generation. They also may provide useful biomarkers for the diagnosis, prognosis, and treatment of adverse prenatal exposures.
first_indexed 2024-12-12T13:58:20Z
format Article
id doaj.art-170cb92398bd41cfb9fd6258ba765f79
institution Directory Open Access Journal
issn 1868-7075
1868-7083
language English
last_indexed 2024-12-12T13:58:20Z
publishDate 2017-03-01
publisher BMC
record_format Article
series Clinical Epigenetics
spelling doaj.art-170cb92398bd41cfb9fd6258ba765f792022-12-22T00:22:24ZengBMCClinical Epigenetics1868-70751868-70832017-03-019111110.1186/s13148-017-0329-3Epigenetic signatures of gestational diabetes mellitus on cord blood methylationLarissa Haertle0Nady El Hajj1Marcus Dittrich2Tobias Müller3Indrajit Nanda4Harald Lehnen5Thomas Haaf6Institute of Human Genetics, Julius-Maximilians-Universität Würzburg, BiozentrumInstitute of Human Genetics, Julius-Maximilians-Universität Würzburg, BiozentrumInstitute of Human Genetics, Julius-Maximilians-Universität Würzburg, BiozentrumDepartment of Bioinformatics, Julius Maximilians UniversityInstitute of Human Genetics, Julius-Maximilians-Universität Würzburg, BiozentrumDepartment of Gynecology and Obstetrics, Municipal ClinicsInstitute of Human Genetics, Julius-Maximilians-Universität Würzburg, BiozentrumAbstract Background Intrauterine exposure to gestational diabetes mellitus (GDM) confers a lifelong increased risk for metabolic and other complex disorders to the offspring. GDM-induced epigenetic modifications modulating gene regulation and persisting into later life are generally assumed to mediate these elevated disease susceptibilities. To identify candidate genes for fetal programming, we compared genome-wide methylation patterns of fetal cord bloods (FCBs) from GDM and control pregnancies. Methods and results Using Illumina’s 450K methylation arrays and following correction for multiple testing, 65 CpG sites (52 associated with genes) displayed significant methylation differences between GDM and control samples. Four candidate genes, ATP5A1, MFAP4, PRKCH, and SLC17A4, from our methylation screen and one, HIF3A, from the literature were validated by bisulfite pyrosequencing. The effects remained significant after adjustment for the confounding factors maternal BMI, gestational week, and fetal sex in a multivariate regression model. In general, GDM effects on FCB methylation were more pronounced in women with insulin-dependent GDM who had a more severe metabolic phenotype than women with dietetically treated GDM. Conclusions Our study supports an association between maternal GDM and the epigenetic status of the exposed offspring. Consistent with a multifactorial disease model, the observed FCB methylation changes are of small effect size but affect multiple genes/loci. The identified genes are primary candidates for transmitting GDM effects to the next generation. They also may provide useful biomarkers for the diagnosis, prognosis, and treatment of adverse prenatal exposures.http://link.springer.com/article/10.1186/s13148-017-0329-3DNA methylationFetal cord bloodFetal programmingGestational diabetes mellitusInsulin treatment
spellingShingle Larissa Haertle
Nady El Hajj
Marcus Dittrich
Tobias Müller
Indrajit Nanda
Harald Lehnen
Thomas Haaf
Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
Clinical Epigenetics
DNA methylation
Fetal cord blood
Fetal programming
Gestational diabetes mellitus
Insulin treatment
title Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
title_full Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
title_fullStr Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
title_full_unstemmed Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
title_short Epigenetic signatures of gestational diabetes mellitus on cord blood methylation
title_sort epigenetic signatures of gestational diabetes mellitus on cord blood methylation
topic DNA methylation
Fetal cord blood
Fetal programming
Gestational diabetes mellitus
Insulin treatment
url http://link.springer.com/article/10.1186/s13148-017-0329-3
work_keys_str_mv AT larissahaertle epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT nadyelhajj epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT marcusdittrich epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT tobiasmuller epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT indrajitnanda epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT haraldlehnen epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation
AT thomashaaf epigeneticsignaturesofgestationaldiabetesmellitusoncordbloodmethylation